Predictive role of REG IV and YKL-40 in locally advanced rectal cancer patients receiving neoadjuvant chemoradiotherapy

Faculty Medicine Year: 2017
Type of Publication: ZU Hosted Pages:
Authors:
Journal: Turkish Journal of Pathology journal of interdisciplinary histopathology, vol 6, no. 1, page 15–25 Volume:
Keywords : Predictive role , , , , YKL-40 , locally advanced rectal    
Abstract:
ABSTRACT Objective: Patients with locally advanced rectal cancer (LARC) need extensive surgical interference. Preoperative neoadjuvant chemoradiotherapy (CRT) shifts this extensive surgical procedure to another sphincter saving one as well as lowers patient’s morbidity and mortality. Till now, there is no definite method to predict patients’ response toneoadjuvant CRT Methods: REG IV and YKL-40 immunohistochemistry were evaluated in pre-treatment endoscopic biopsies from 42 LARC cases who received neoadjuvant CRT followed by surgical interference. The findings were correlated with the clinico-pathological features, tumor response, and tumor regression grade of the post-operative specimens. Results: REG IV high expression was associated with advanced post-treatment pathological tumor status, post-treatment pathological nodal status and presence of lympho vascular invasion with statistical significance. Furthermore, it was correlated witha lower extent of tumor regression after neoadjuvant CRT. All patients with pathological complete response exhibited negative/low REG IV expression and only 13.6% of theresponders showed high REG IV expression with statistical significance. YKL-40 immunohistochemicalexpression was highly associated with the tumor regression rate where of LARC patients with poor neoadjuvant CRT response highly expressed YKL-40 and66.6% of patients with complete regression showed negative/low expression of YKL-40. Conclusion: Our findings implicate REG IV and YKL-40 as important predictors of neoadjuvant CRT response in LARC.
   
     
 
       

Author Related Publications

  • Mohamed Abdel Gawad Souleiman, "Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer:An Immunohistochemical Study", Turkish Journal of Pathology, 2017 More
  • Mohamed Abdel Gawad Souleiman, "Prognostic impact of EGFR and cytokeratin 5/6 immunohistochemical expression in triple-negative breast cancer", Elsevier, 2017 More
  • Mohamed Abdel Gawad Souleiman, "HYPOFRACTIONATED RADIOTHERAPY VERSUS CONVENTIONAL RADIOTHERAPY IN TREATMENT OF GLIOBLASTOMA MULTIFORME", PAN ARAB JOURNAL OF ONCOLOGY, 2011 More
  • Mohamed Abdel Gawad Souleiman, "METRONOMIC CHEMOTHERAPY AS A PALLIATIVE TREATMENT IN POOR PERFORMANCE STATUS PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CARCINOMA", springer, 2011 More
  • Mohamed Abdel Gawad Souleiman, "Re-Irradiation in Recurrent High-Grade Glioma", The medical journal of cairo university, 2012 More

Department Related Publications

  • Walid Elsayed Hamouda, "مقارنه العلاج الاشعاعى مع التيمودال بالعلاج الاشعاعى المنفرد في حالات اورام المخ من الدرجة الثالثه والرابعه ", لايوجد, 1900 More
  • Walid Elsayed Hamouda, "مقارنه العلاج الاشعاعي بجلسه واحده بالعلاج التقليدي في تسكين الالم في حالات ثانويات العظام", لايوجد, 1900 More
  • Ashraf Yousry Ahmed Gendya, "التحديد الموضعى للغدة الليمفاوية الحارسة بمساعدة المسح الذرى مع اخذ عينة فى علاج سرطان الثدى الغازى المبكر", المجلة الطبية لجامعة الزقازيق, 2006 More
  • Reham Safwat Elsayed Fahmy, "دور العلاج بالجيمستابين والسيبسلاتين كعلاج كيماوى اولى في حالات سرطان الرئة المتقدمه", (طب الزقازيق - المعهد القومى للاورام), 2000 More
  • Seham Mohamed Alhagrasy Rezk, "دور العلاج الاشعاعى والكيماوى المكمل في حالات اورام ماحول قمع فاتر (البنكرياسيه والغير بنكرياسيه )بعد الجراحة", لايوجد, 1900 More
Tweet